Anika Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Anika Therapeutics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 7% to $166,662,000. Profit margin reached -50%. Total operating expenses were $191,475,000.
Profit Margin
| 2014 | 105.59M | 38.31M | 36.29% |
|---|---|---|---|
| 2015 | 92.99M | 30.75M | 33.07% |
| 2016 | 103.37M | 32.54M | 31.48% |
| 2017 | 113.42M | 31.81M | 28.05% |
| 2018 | 105.55M | 18.72M | 17.74% |
| 2019 | 114.61M | 27.19M | 23.73% |
| 2020 | 130.45M | -23.98M | -18.38% |
| 2021 | 147.79M | 4.13M | 2.8% |
| 2022 | 156.23M | -14.85M | -9.51% |
| 2023 | 166.66M | -82.66M | -49.6% |
ANIK Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 166.66M | 156.23M | 147.79M | 130.45M | 114.61M | 105.55M | 113.42M | 103.37M | 92.99M | 105.59M |
Cost of revenue | 63.57M | 62.66M | 64.85M | 61.43M | 28.74M | 31.28M | 27.36M | 24.02M | 21.05M | 20.93M |
Gross profit | 103.08M | 93.57M | 82.94M | 69.02M | 85.86M | 74.27M | 86.05M | 79.35M | 71.94M | 84.66M |
Operating exp. | ||||||||||
Research and development | 32.68M | 28.18M | 27.32M | 23.43M | 16.66M | 18.19M | 18.78M | 10.73M | 8.98M | 8.14M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 191.47M | 112.97M | 101.42M | 83.49M | 51.61M | 52.52M | 40.32M | 28.74M | 23.81M | 23.21M |
Operating income | -87.63M | -19.4M | -18.48M | -14.46M | 34.24M | 21.74M | 45.72M | 50.60M | 48.13M | 61.44M |
Other income (expenses), net | 2.31M | 654K | 20.90M | -302K | 1.87M | 1.45M | 473K | 263K | 120K | 58.13K |
Income before tax | -85.32M | -18.74M | 2.42M | -28.62M | 36.12M | 23.20M | 46.20M | 50.87M | 48.25M | 61.50M |
Income tax expense | -2.66M | -3.88M | -1.70M | -4.64M | 8.92M | 4.48M | 14.38M | 18.32M | 17.49M | 23.18M |
Net income | -82.66M | -14.85M | 4.13M | -23.98M | 27.19M | 18.72M | 31.81M | 32.54M | 30.75M | 38.31M |
Earnings per share | ||||||||||
Basic EPS | -5.64 | -1.02 | 0.29 | -1.69 | 1.93 | 1.3 | 2.18 | 2.22 | 2.06 | 2.61 |
Diluted EPS | -5.64 | -1.02 | 0.28 | -1.69 | 1.89 | 1.27 | 2.11 | 2.15 | 2.01 | 2.51 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |